Cargando…

What do letters to the editor publish about randomized controlled trials? A cross-sectional study

BACKGROUND: To identify published letters to the editor (LTE) written in response to randomized controlled trials (RCTs), determine the topics addressed in the letters, and to examine if these topics were affected by the characteristics and results of the RCTs. METHODS: Comparative cross-sectional s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kastner, Monika, Menon, Anita, Straus, Sharon E, Laupacis, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852599/
https://www.ncbi.nlm.nih.gov/pubmed/24124753
http://dx.doi.org/10.1186/1756-0500-6-414
_version_ 1782478694976061440
author Kastner, Monika
Menon, Anita
Straus, Sharon E
Laupacis, Andreas
author_facet Kastner, Monika
Menon, Anita
Straus, Sharon E
Laupacis, Andreas
author_sort Kastner, Monika
collection PubMed
description BACKGROUND: To identify published letters to the editor (LTE) written in response to randomized controlled trials (RCTs), determine the topics addressed in the letters, and to examine if these topics were affected by the characteristics and results of the RCTs. METHODS: Comparative cross-sectional study of a representative sample of RCTs from a set of high-impact medical journals (BMJ, Lancet, NEJM, JAMA, and Annals of Internal Medicine). RCTs and their published LTE were searched from these 5 journals in 2007. Data were collected on RCTs and their characteristics (author affiliation, funding source, intervention, and effect on the primary outcome) and the topics addressed in published LTE related to these RCTs. Analysis included chi-square and regression analysis (RCT characteristics) and thematic analysis (LTE topics). RESULTS: Of 334 identified RCTs, 175 trials had at least one LTE. Of these, 381 published LTE were identified. Most RCTs, tested drug interventions (68%), were funded by government (54%) or industry (33%), and described an intervention that had a positive impact on the primary outcome (62%). RCT authors were primarily affiliated with an academic centre (78%). Ninety percent of the 623 LTE topics concerned methodological issues regarding the analysis, intervention, and population in the RCT. There was a significant association between funding source and impact on outcomes (p = 0.002) or type of intervention tested (p = 0.001) in these trials. Clinical and “Other” LTE topics were more likely to be published in response to a government funded RCT (p = 0.005 and p = 0.033, respectively); no other comparisons were significant. CONCLUSIONS: This study showed that most LTE are about methodological topics, but found little evidence to support that these topics are affected by the characteristics or results of the RCTs. The lack of association may be explained by editorial censorship as a small proportion of LTE that are submitted are actually published.
format Online
Article
Text
id pubmed-3852599
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38525992013-12-06 What do letters to the editor publish about randomized controlled trials? A cross-sectional study Kastner, Monika Menon, Anita Straus, Sharon E Laupacis, Andreas BMC Res Notes Research Article BACKGROUND: To identify published letters to the editor (LTE) written in response to randomized controlled trials (RCTs), determine the topics addressed in the letters, and to examine if these topics were affected by the characteristics and results of the RCTs. METHODS: Comparative cross-sectional study of a representative sample of RCTs from a set of high-impact medical journals (BMJ, Lancet, NEJM, JAMA, and Annals of Internal Medicine). RCTs and their published LTE were searched from these 5 journals in 2007. Data were collected on RCTs and their characteristics (author affiliation, funding source, intervention, and effect on the primary outcome) and the topics addressed in published LTE related to these RCTs. Analysis included chi-square and regression analysis (RCT characteristics) and thematic analysis (LTE topics). RESULTS: Of 334 identified RCTs, 175 trials had at least one LTE. Of these, 381 published LTE were identified. Most RCTs, tested drug interventions (68%), were funded by government (54%) or industry (33%), and described an intervention that had a positive impact on the primary outcome (62%). RCT authors were primarily affiliated with an academic centre (78%). Ninety percent of the 623 LTE topics concerned methodological issues regarding the analysis, intervention, and population in the RCT. There was a significant association between funding source and impact on outcomes (p = 0.002) or type of intervention tested (p = 0.001) in these trials. Clinical and “Other” LTE topics were more likely to be published in response to a government funded RCT (p = 0.005 and p = 0.033, respectively); no other comparisons were significant. CONCLUSIONS: This study showed that most LTE are about methodological topics, but found little evidence to support that these topics are affected by the characteristics or results of the RCTs. The lack of association may be explained by editorial censorship as a small proportion of LTE that are submitted are actually published. BioMed Central 2013-10-14 /pmc/articles/PMC3852599/ /pubmed/24124753 http://dx.doi.org/10.1186/1756-0500-6-414 Text en Copyright © 2013 Kastner et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kastner, Monika
Menon, Anita
Straus, Sharon E
Laupacis, Andreas
What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title_full What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title_fullStr What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title_full_unstemmed What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title_short What do letters to the editor publish about randomized controlled trials? A cross-sectional study
title_sort what do letters to the editor publish about randomized controlled trials? a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852599/
https://www.ncbi.nlm.nih.gov/pubmed/24124753
http://dx.doi.org/10.1186/1756-0500-6-414
work_keys_str_mv AT kastnermonika whatdoletterstotheeditorpublishaboutrandomizedcontrolledtrialsacrosssectionalstudy
AT menonanita whatdoletterstotheeditorpublishaboutrandomizedcontrolledtrialsacrosssectionalstudy
AT straussharone whatdoletterstotheeditorpublishaboutrandomizedcontrolledtrialsacrosssectionalstudy
AT laupacisandreas whatdoletterstotheeditorpublishaboutrandomizedcontrolledtrialsacrosssectionalstudy